Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA

FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient

More from Archive

More from Pink Sheet